Veru Inc. Files S-3 Registration Statement
Ticker: VERU · Form: S-3 · Filed: 2026-04-07T16:18:22-04:00
Sentiment: neutral
Topics: registration-statement, securities-offering, pharmaceutical
TL;DR
VERU filed an S-3, looks like they're planning to sell more stock soon.
AI Summary
Veru Inc. filed an S-3 registration statement on April 7, 2026, indicating plans to offer and sell securities. The filing details the company's business, financial condition, and the terms of the securities being offered, though specific dollar amounts for the offering are not yet detailed in this initial registration. Veru Inc. is a pharmaceutical company incorporated in Wisconsin.
Why It Matters
This S-3 filing signals Veru Inc.'s intention to raise capital by issuing new securities, which could impact its stock price and financial structure.
Risk Assessment
Risk Level: medium — An S-3 filing indicates potential future stock offerings, which can dilute existing shareholders and introduce market uncertainty.
Key Numbers
- 302014 — S-3 Document Size (Size of the primary S-3 registration document in bytes.)
- 903250 — Complete Submission Text File Size (Total size of the complete submission text file in bytes.)
Key Players & Entities
- Veru Inc. (company) — Filer of the S-3 registration statement
- 0000863894 (company) — CIK number for Veru Inc.
- 2026-04-07 (date) — Filing date of the S-3 registration statement
- 333-294911 (other) — File number associated with the S-3 filing
FAQ
What is the purpose of this S-3 filing?
The S-3 filing is a registration statement under the Securities Act of 1933, indicating Veru Inc.'s intent to offer and sell securities.
When was this S-3 filing submitted?
The S-3 filing was submitted and accepted on April 7, 2026.
What is Veru Inc.'s CIK number?
Veru Inc.'s CIK number is 0000863894.
What is the state of incorporation for Veru Inc.?
Veru Inc. is incorporated in Wisconsin (WI).
What is the SIC code for Veru Inc.?
The SIC code for Veru Inc. is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001193125-26-145576 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form S-3 - Registration statement under Securities Act of 1933: SEC Accession No. 0001193125-26-145576 Filing Date 2026-04-07 Accepted 2026-04-07 16:18:22 Documents 18 Interactive Data Document Format Files Seq Description Document Type Size 1 S-3 d84893ds3.htm S-3 302014 2 EX-4.13 d84893dex413.htm EX-4.13 275153 3 EX-5.1 d84893dex51.htm EX-5.1 19530 4 EX-5.2 d84893dex52.htm EX-5.2 16559 5 EX-23.1 d84893dex231.htm EX-23.1 1590 6 EX-FILING FEES d84893dexfilingfees.htm iXBRL EX-FILING FEES 31268 7 GRAPHIC g84893g46p03.jpg GRAPHIC 61790 8 GRAPHIC g84893g70o20.jpg GRAPHIC 5680 9 GRAPHIC g84893g78r36.jpg GRAPHIC 4236 Complete submission text file 0001193125-26-145576.txt 903250 Data Files Seq Description Document Type Size 21 EXTRACTED XBRL INSTANCE DOCUMENT d84893dexfilingfees_htm.xml XML 13498 Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123 VERU INC. (Filer) CIK : 0000863894 (see all company filings) EIN. : 391144397 | State of Incorp.: WI | Fiscal Year End: 0930 Type: S-3 | Act: 33 | File No.: 333-294911 | Film No.: 26845165 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)